series-b
Stage
2015
Founded
1
Investors
About
Sigilon Therapeutics develops biopharmaceutical therapies that use encapsulated cell technology to provide long-lasting treatment for chronic diseases.
Explore Sigilon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.